Is Cibus Inc. Class A Common Stock a good investment? Cibus Inc. Class A Common Stock (CBUS) is currently trading at 1.63 USD. Market analysts have a consensus price target of 14.33 USD. This suggests a potential upside from current levels.
Earnings Schedule: Cibus Inc. Class A Common Stock is expected to release its next earnings report on Nov. 12, 2026. The market consensus estimate for Forward EPS is -0.64.
No, it does not currently pay a dividend.
Cibus Inc. Class A Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Nov. 12, 2026. The company currently has a trailing EPS of -1.51.
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
| Split Date | Split Ratio to 1 |
|---|---|
| April 25, 2023 | 1:10 |
| June 1, 2023 | 1:5 |
Community Discussion